A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer Intervention: Drug: PLB1004 Sponsor: Avistone Biotechnology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Oral Cancer | Research | Study